These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38214512)

  • 41. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
    Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
    Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
    Salehi B; Ghalavand Z; Mohammadzadeh M; Maleki DT; Kodori M; Kadkhoda H
    J Appl Microbiol; 2019 Nov; 127(5):1421-1429. PubMed ID: 31400237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    Yoon EJ; Kim HS; Woo H; Choi YJ; Won D; Choi JR; Kim YA; Jeong SH
    J Antimicrob Chemother; 2021 Dec; 77(1):69-73. PubMed ID: 34609499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
    Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
    Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii.
    Kang KN; Kazi MI; Biboy J; Gray J; Bovermann H; Ausman J; Boutte CC; Vollmer W; Boll JM
    mBio; 2021 Jan; 12(1):. PubMed ID: 33402533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic and molecular characterisations of carbapenem-resistant
    Simo Tchuinte PL; Rabenandrasana MAN; Kowalewicz C; Andrianoelina VH; Rakotondrasoa A; Andrianirina ZZ; Enouf V; Ratsima EH; Randrianirina F; Collard JM
    Antimicrob Resist Infect Control; 2019; 8():31. PubMed ID: 30792853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant
    Ilsan NA; Lee YJ; Kuo SC; Lee IH; Huang TW
    Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34198665
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
    Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
    Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
    Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
    Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran.
    Alaei N; Aziemzadeh M; Bahador A
    J Glob Antimicrob Resist; 2016 Jun; 5():75-9. PubMed ID: 27436472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial resistance genes harbored in invasive
    Kang HM; Kim KR; Kim G; Lee DG; Kim YJ; Choi EH; Lee J; Yun KW
    Front Cell Infect Microbiol; 2024; 14():1410997. PubMed ID: 39027135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the genetic elements bla oxa and IS Aba 1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting.
    Kobs VC; Ferreira JA; Bobrowicz TA; Ferreira LE; Deglmann RC; Westphal GA; França PH
    Rev Soc Bras Med Trop; 2016; 49(4):433-40. PubMed ID: 27598629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel approaches to overcome Colistin resistance in Acinetobacter baumannii: Exploring quorum quenching as a potential solution.
    Khoshbakht R; Panahi S; Neshani A; Ghavidel M; Ghazvini K
    Microb Pathog; 2023 Sep; 182():106264. PubMed ID: 37474078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.